Jim Costas

Territory Business Manager at Circassia

Jim Costas's Professional Contact Details

Email (Verified)

****@circassia.com

Get Email Address

+44 1865 405560

Location

Atlanta, Georgia, US

Company

Circassia

Person Seniority

manager

Person Functions

business development

Jim Costas's Current Company Details

Circassia

Oxford, England, United Kingdom • 266 Employees

biotechnology

Circassia is a world-class specialty pharmaceutical business focused on respiratory disease. Circassia sells its novel, market-leading NIOXÂ® asthma management products directly to specialists in the United States, United Kingdom and Germany, and in a wide range of other countries through its network of partners. The Company recently established a collaboration with AstraZeneca in the US in which it promotes the chronic obstructive pulmonary disease (COPD) treatment TudorzaÂ®, and has the US commercial rights to late-stage COPD product DuaklirÂ®. Circassia's development pipeline includes a range of respiratory medicines. The Company's lead asthma treatment targets substitution of GSK's FlixotideÂ® pMDI and was approved in the UK. Circassia is also developing a direct substitute for SeretideÂ® pMDI, and its pipeline includes a number of inhaled medicines for COPD, including single and combination dose products. For more information on Circassia please visit www.circassia.com.

Public Symbol

CIR

Founded Year

2006

Organization Website

circassia.com

Organization Languages

English, English

Organization Revenue

15400

Alexa Ranking

537886